Now retired, William Deyesso is an experienced executive who most recently worked as the executive vice president for Wynn Management and Development Co, a real estate management and development firm out of Boston, Massachusetts. Throughout his life, William Deyesso has demonstrated a keen interest in supporting multiple charities and organizations, including the American Cancer Society (ACS).
Research gathered and published by the ACS shows that the death rate for cancer in both male and female patients decreased 25 percent between 1991 and 2014. The data suggests that for the period, over 2.1 million cancer deaths were avoided.
While the diagnosis rate among women has seen no noticeable change, cancer diagnosis in males has gone down roughly 2 percent per year for the two decades measured. The decline in male detection is partially attributed to the decreased rate of prostate cancer diagnosis. The prostate-specific antigen blood testing method used to test for prostate cancer often led to over-diagnosis, which has gone down as the testing method loses favor.
According to the ACS chief medical officer, Otis W. Brawley, MD, FACP, the lowered statistics represent “a powerful sign of the potential we have to reduce cancer’s deadly toll.” Continued success, Brawley says, relies on researching treatment and early detection systems, while also focusing more on our health, as a nation.
